Surmodics Inc (SRDX) - News Archive

In a significant advancement for vascular intervention, Surmodics, Inc. a prominent player in the medical device and in vitro diagnostic technology sector, has announced that it has received clearance from the U.S. Food...

In a landscape that demands agility and foresight, Surmodics, Inc. (Nasdaq: SRDX), headquartered in Eden Prairie, Minnesota, finds itself at a pivotal junction as it reports its financial results for the third quarter o...

Eden Prairie, Minn. - Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, has announced a significant achievement in the healthcare sector. The company has been awa...

Distinguished in the healthcare industry for their continuous innovation, Surmodics, Inc., headquartered in Eden Prairie, Minnesota, reported total revenue of $32.0 million for the second quarter of the fiscal year 2024...

Surmodics, a renowned provider of medical device and in vitro diagnostic technologies, recently presented the noteworthy 24-month data from the SWING Trial at the prestigious 50th annual VEITH Symposium in New York. The...

Surmodics Announces Positive 24-Month Data from SWING Trial at VEITH SymposiumSurmodics, Inc., a prominent provider of medical device and in-vitro diagnostic technologies, has recently revealed exciting news regarding t...

Surmodics Revolutionizes Medical Device Coating Technology with Preside, Enhancing Neurovascular ProceduresEDEN PRAIRIE, Minn. - Surmodics, Inc. (NASDAQ: SRDX), the renowned pioneer in medical device coating technologie...